Sign In
Buy PFE
$27.05
+0.290 (+1.08%)
At Close: Aug 10, 2026
Pfizer Post Loss on Higher Revenue
07:24am, Tuesday, 04'th Aug 2026
Pfizer swung to a second-quarter loss but posted higher revenue, as market growth in its oncology business offset some declines in its Covid-19 products.
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
07:13am, Tuesday, 04'th Aug 2026
Pfizer reported second-quarter results that topped estimates and hiked the low end of its revenue outlook, citing the stronger-than-expected performance of non-Covid products. The company is now exp
Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings
07:12am, Tuesday, 04'th Aug 2026
Pfizer beats earnings forecasts for the second quarter, while BioNTech's results miss expectations due to weak Covid vaccine demand.
Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
06:52am, Tuesday, 04'th Aug 2026
Pfizer beat Wall Street estimates for second-quarter profit on Tuesday, driven by strong demand for its blood thinner, Eliquis.
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
06:45am, Tuesday, 04'th Aug 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2026 and raised its full-year 2026 Revenue guidance by $500 million at the midpoint while reaffi
Caterpillar, Pfizer and 3 Stocks to Watch Heading Into Tuesday
06:29am, Tuesday, 04'th Aug 2026
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Pfizer raises revenue outlook after quarterly earnings top estimates
06:26am, Tuesday, 04'th Aug 2026
Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue...
Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
01:55am, Tuesday, 04'th Aug 2026
Pfizer Inc. (NYSE:PFE) will release its second quarter earnings report before the opening bell on Tuesday, Aug. 4.
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
02:32pm, Monday, 03'rd Aug 2026
The stock's yield is more than six times the S&P 500 average.
5 Things to Know Before the Stock Market Opens on Monday
08:10am, Monday, 03'rd Aug 2026
Stock futures are pointing to a higher open to kick off August trading as investors look ahead to a packed week of earnings reports; oil prices are tumbling after the U.S. paused strikes on Iran over
Pfizer (PFE) Expected to Post Quarterly Earnings on Tuesday
04:45am, Monday, 03'rd Aug 2026
Pfizer (NYSE: PFE - Get Free Report) is projected to announce its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to announce earnings of $0.68 per share an
Pfizer's financial results haven't been great, and upcoming patent cliffs could exacerbate the problem. However, the company's large pipeline across multiple lucrative areas could allow it to bounce b
Pfizer's Bear Case Is Breaking
11:04am, Friday, 31'st Jul 2026
Pfizer's non-COVID commercial portfolio is accelerating, with new launches and business development products growing 22% to a nearly $12 billion annualized run rate. Seagen's oncology portfolio expand
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
10:01am, Friday, 31'st Jul 2026
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Pfizer: Still Mispriced By Mr. Market (Earnings Preview)
10:00am, Friday, 31'st Jul 2026
Pfizer remains a Buy, with a 16% nominal upside and ~7% dividend yield, driven by a diversified, expanding product portfolio. PFE's new growth portfolio, cost controls, and business reorganization are
